Strategy for a Biomimetic Paradigm in Dental and Craniofacial Tissue Engineering - Biomimetics: Advancing Nanobiomaterials and Tissue Engineering - page 150

55. M. Mina and E.J. Kollar, The induction of odontogenesis in non-dental mes-
enchyme combined with early murine mandibular arch epithelium, Arch.
Oral Biol., Vol. 32, pp. 123-7, 1987.
56. A.G.S. Lumsden, Development, vol.Vol. 103, p. 155, 1988.
57. I. Thesleff, Epithelial-mesenchymal signalling regulating tooth morphogen-
esis, J. Cell Sci., Vol. 116, pp. 1647-8, May 1 2003.
58. E.J. Kollar and G.R. Baird, Embryol. Exp. Morphol, Vol. 24, p. 173, 1970.
59. S. Gronthos, M. Mankani, J. Brahim, P.G. Robey, and S. Shi, Postnatal human
dental pulp stem cells (DPSCs) in vitro and in vivo, Proc. Natl. Acad. Sci.
U.S.A., Vol. 97, pp. 13625-30, Dec 5 2000.
60. J. Jernvall and I. Thesleff, Reiterative signaling and patterning during mam-
malian tooth morphogenesis, Mech. Dev., Vol. 92, pp. 19-29, Mar 15 2000.
61. Y. Shinmura, S. Tsuchiya, K. Hata, and M.J. Honda, Quiescent epithelial cell
rests of Malassez can differentiate into ameloblast-like cells, J. Cell Physiol.,
Vol. 217, pp. 728-38, Dec 2008.
62. B.M. Seo, M. Miura, S. Gronthos, P.M. Bartold, S. Batouli, J. Brahim, M. Young,
P.G. Robey, C.Y. Wang, and S. Shi, Investigation of multipotent postnatal
stem cells from human periodontal ligament, Lancet, Vol. 364, pp. 149-55,
Jul 10-16 2004.
63. I. Thesleff and M. Tummers, Tooth organogenesis and regeneration, in
StemBook, Cambridge (MA), 2008.
64. P.A. Trainor, D. Sobieszczuk, D. Wilkinson, and R. Krumlauf, Signalling
between the hindbrain and paraxial tissues dictates neural crest migration
pathways, Development, Vol. 129, pp. 433-42, Jan 2002.
65. S. Yasser, N. Nagy, and M.K. Marei, Maced. J. Med. Sci., Vol. http://dx.doi.
org/10.3889/MJMS.1857- 5773.2012.0249, 2012.
66. A.I. Caplan and D. Correa, The MSC: An injury drugstore, Cell Stem Cell, Vol.
9, pp. 11-5, Jul 8 2011.
67. R.M. El Backly and R. Cancedda, Bone marrow stem cells in clinical applica-
tion: harnessing paracrine roles and niche mechanisms, Adv. Biochem. Eng.
Biotechnol., Vol. 123, pp. 265-92, 2010.
68. S.H. Ranganath, O. Levy, M.S. Inamdar, and J.M. Karp, Harnessing the mes-
enchymal stem cell secretome for the treatment of cardiovascular disease,
Cell Stem Cell, Vol. 10, pp. 244-58, Mar 2 2012.
69. T. Schinkothe, W. Bloch, and A. Schmidt, In vitro secreting profi le of human
mesenchymal stem cells, Stem Cells Dev., Vol. 17, pp. 199-206, Feb 2008.
70. M. Heil, T. Ziegelhoeffer, B. Mees, and W. Schaper, A different outlook on the
role of bone marrow stem cells in vascular growth: Bone marrow delivers
software not hardware, Circ. Res., Vol. 94, pp. 573-4, Mar 19 2004.
71. S. Roche, G. D'Ippolito, L.A. Gomez, T. Bouckenooghe, S. Lehmann,
C.N. Montero-Menei, and P.C. Schiller, Comparative analysis of protein
expression of three stem cell populations: Models of cytokine delivery sys-
tem in vivo, Int. J. Pharm., Jan 20 2012.
72. A. Oskowitz, H. McFerrin, M. Gutschow, M.L. Carter, and R. Pochampally,
Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are
highly angiogenic, Stem Cell Res., Vol. 6, pp. 215-25, May 2011.
73. E. Potier, E. Ferreira, R. Andriamanalijaona, J.P. Pujol, K. Oudina, D. Logeart-
Avramoglou, and H. Petite, Hypoxia affects mesenchymal stromal cell